Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    NCT01876446
Previous Study | Return to List | Next Study

Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Roswell Park Cancer Institute
National Cancer Institute (NCI)
Nektar Therapeutics
Information provided by (Responsible Party):
Roswell Park Cancer Institute Identifier:
First received: June 10, 2013
Last updated: September 2, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)